Nordea Investment Management AB Decreases Position in UnitedHealth Group Incorporated $UNH

Key Points

• Nordea Investment Management AB reduced its position in UnitedHealth Group by **34.6%**, selling **80,826 shares** and bringing its total holdings to **153,004 shares** valued at **$47.11 million**.
• In the most recent earnings report, UnitedHealth Group missed analysts' expectations with an EPS of **$4.08**, compared to the predicted **$4.45**, while quarterly revenue showed a **12.9% increase** year-over-year.
• The company declared a quarterly dividend of **$2.21**, resulting in an annualized dividend yield of **2.5%**, with a dividend payout ratio of **38.30%**.

Nordea Investment Management AB trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 34.6% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 153,004 shares of the healthcare conglomerate's stock after selling 80,826 shares during the quarter. Nordea Investment Management AB's holdings in UnitedHealth Group were worth $47,113,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the company. Citizens National Bank Trust Department lifted its position in shares of UnitedHealth Group by 1.0% in the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock valued at $9,368,000 after acquiring an additional 170 shares in the last quarter. Caitlin John LLC lifted its position in shares of UnitedHealth Group by 14.8% in the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock valued at $451,000 after acquiring an additional 111 shares in the last quarter. Triumph Capital Management purchased a new stake in shares of UnitedHealth Group in the second quarter valued at $1,324,000. Wealth Effects LLC lifted its position in UnitedHealth Group by 14.4% during the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate's stock worth $1,463,000 after buying an additional 591 shares during the period. Finally, Arlington Partners LLC purchased a new position in UnitedHealth Group during the second quarter worth about $2,229,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

UNH stock opened at $356.53 on Friday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The firm has a market cap of $322.90 billion, a P/E ratio of 15.45, a price-to-earnings-growth ratio of 2.31 and a beta of 0.47. The stock has a 50-day simple moving average of $329.38 and a 200-day simple moving average of $343.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same quarter last year, the business posted $6.80 EPS. UnitedHealth Group's quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on UNH shares. KeyCorp increased their target price on UnitedHealth Group from $350.00 to $400.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 8th. Mizuho increased their target price on UnitedHealth Group from $300.00 to $430.00 and gave the stock an "outperform" rating in a research report on Thursday, October 9th. Royal Bank Of Canada reduced their target price on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Morgan Stanley raised their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a report on Friday, September 12th. Finally, JPMorgan Chase & Co. raised their price objective on UnitedHealth Group from $310.00 to $425.00 and gave the stock an "overweight" rating in a report on Thursday, October 9th. Eighteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of "Hold" and a consensus price target of $385.13.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.